| Clinical data | |
|---|---|
| Other names | 4-Hydroxy-N-propyltryptamine |
| Drug class | Serotonin receptor modulator; Serotonin 5-HT2A receptor agonist; Serotonergic psychedelic; Hallucinogen |
| ATC code |
|
| Identifiers | |
| |
| PubChem CID | |
| Chemical and physical data | |
| Formula | C13H18N2O |
| Molar mass | 218.300 g·mol−1 |
| 3D model (JSmol) | |
| |
| |
4-HO-NPT, also known as 4-hydroxy-N-propyltryptamine, is a serotonin receptor modulator and putative psychedelic drug of the tryptamine and 4-hydroxytryptamine families related to norpsilocin (4-HO-NMT).[1] It was not included by Alexander Shulgin in his 1997 book TiHKAL (Tryptamines I Have Known and Loved) and its properties and effects in humans are unknown.[2] The drug acts as a non-selective serotonin receptor agonist, including of the serotonin 5-HT2A receptor.[1] It produces the head-twitch response, a behavioral proxy of psychedelic effects, in rodents, albeit with about 26-fold lower potency than psilocin (4-HO-DMT).[1] Unlike 4-HO-NPT, norpsilocin is notably inactive in this test.[1] In addition to its psychedelic-like effects, 4-HO-NPT produces hypolocomotion and hypothermia in rodents.[1] 4-HO-NPT was first described in the scientific literature by Alexander Sherwood and colleagues by 2024.[1]
See also
- Substituted tryptamine
- 4-HO-DPT (deprocin)
References
- Sherwood AM, Burkhartzmeyer EK, Williamson SE, Baumann MH, Glatfelter GC (January 2024). "Psychedelic-like Activity of Norpsilocin Analogues". ACS Chemical Neuroscience. 15 (2): 315–327. doi:10.1021/acschemneuro.3c00610. PMC 10797613. PMID 38189238.
- Shulgin A, Shulgin A (September 1997). TiHKAL: The Continuation. Berkeley, California: Transform Press. ISBN 0-9630096-9-9. OCLC 38503252.